Yes, we make those, too!
Recent papers from the Feng Zhang lab at the Broad Institute and Stanley Qi lab from Stanford demonstrate the incredible potential of CRISPR-Cas13 for SARS-CoV-2 detection as well as the development of COVID-19 therapies. If your research includes CRISPR-Cas13 or other exotic Cas systems, IDT is the quality choice for custom guide RNAs.
We are a global leader in CRISPR genome editing, and researchers turn to us first for custom guides and other oligos. Here’s why:
We know your research is now more urgent than ever, and we’ll prioritize your inquiry. Please complete this short form, and we’ll be in touch to discuss your project ASAP.